Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Novel P-CAB dual therapy for Helicobacter pylori infection
ChiCTR2400082371Phase 4Recruiting
- Sponsor
- Tongji Hospital
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tegoprazan, vonoprazan and amoxicillin in Helicobacter pylori infection (4 arms), sponsored by Tongji Hospital. Primary endpoints: Helicobacter pylori eradication rate and Adverse events. Started Jan 2024; status: recruiting.
02
Drugs
tegoprazanvonoprazanamoxicillin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR2400082371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400082371.